Cargando…

MicroRNA let-7c Is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth

PURPOSE: Prostate cancer (PCa) is characterized by deregulated expression of several tumor suppressor or oncogenic miRNAs. The objective of this study was the identification and characterization of miR-let-7c as a potential tumor suppressor in PCa. EXPERIMENTAL DESIGN: Levels of expression of miR-le...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nadiminty, Nagalakshmi, Tummala, Ramakumar, Lou, Wei, Zhu, Yezi, Shi, Xu-Bao, Zou, June X., Chen, Hongwu, Zhang, Jin, Chen, Xinbin, Luo, Jun, deVere White, Ralph W., Kung, Hsing-Jien, Evans, Christopher P., Gao, Allen C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3316551/ https://www.ncbi.nlm.nih.gov/pubmed/22479342 http://dx.doi.org/10.1371/journal.pone.0032832

Ejemplares similares

Oncomir miR-125b Suppresses p14(ARF) to Modulate p53-Dependent and p53-Independent Apoptosis in Prostate Cancer
por: Amir, Sumaira, et al.
Publicado: (2013)

microRNAs and prostate cancer
por: Shi, Xu-Bao, et al.
Publicado: (2008)

Targeting Tyrosine Kinases and Autophagy in Prostate Cancer
por: Kung, Hsing-Jien
Publicado: (2010)

Targeting Mitochondrial OXPHOS and Their Regulatory Signals in Prostate Cancers
por: Chen, Chia-Lin, et al.
Publicado: (2021)

Initiation of prostate cancer in mice by Tp53(R270H): evidence for an alternative molecular progression
por: Vinall, Ruth L., et al.
Publicado: (2012)

Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism
por: Shih, Jing-Wen, et al.
Publicado: (2015)

Niclosamide enhances abiraterone treatment via inhibition of androgen receptor variants in castration resistant prostate cancer
por: Liu, Chengfei, et al.
Publicado: (2016)

Targeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft model
por: Nguyen, H G, et al.
Publicado: (2014)

Regulation of androgen receptor variants in prostate cancer
por: Zhu, Yezi, et al.
Publicado: (2020)

Decreased expression of let-7c is associated with non-response of muscle-invasive bladder cancer patients to neoadjuvant chemotherapy
por: Vinall, Ruth L., et al.
Publicado: (2016)

REST is a crucial regulator for acquiring EMT-like and stemness phenotypes in hormone-refractory prostate cancer
por: Chang, Yi-Ting, et al.
Publicado: (2017)

Dysregulation of cystathionine γ‐lyase promotes prostate cancer progression and metastasis
por: Wang, Yi‐Hsiang, et al.
Publicado: (2019)

Agriscience : fundamentals and applications /
por: Burton, L. DeVere
Publicado: (2010)

Agrociencia : fundamentos y aplicaciones /
por: Burton, L. DeVere
Publicado: (2009)

Agrociencia y tecnología
por: Burton, L. DeVere
Publicado: (1999)

Arginine is an epigenetic regulator targeting TEAD4 to modulate OXPHOS in prostate cancer cells
por: Chen, Chia-Lin, et al.
Publicado: (2021)

ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancer
por: Wang, Junjian, et al.
Publicado: (2016)

The Androgen Receptor is a negative regulator of eIF4E Phosphorylation at S209: Implications for the use of mTOR inhibitors in advanced prostate cancer
por: D’Abronzo, Leandro S., et al.
Publicado: (2017)

KDM4B as a Target for Prostate Cancer: Structural Analysis and Selective Inhibition by a Novel Inhibitor
por: Chu, Chia-Han, et al.
Publicado: (2014)

Regulation of PBX3 expression by androgen and Let-7d in prostate cancer
por: Ramberg, Håkon, et al.
Publicado: (2011)

Role of miRNA Let-7 and Its Major Targets in Prostate Cancer
por: Wagner, Siegfried, et al.
Publicado: (2014)

Prostate cancer small extracellular vesicles participate in androgen-independent transformation of prostate cancer by transferring let-7a-5p
por: Lei, Lin, et al.
Publicado: (2022)

Circulating let-7f-5p improve risk prediction of prostate cancer in patients with benign prostatic hyperplasia
por: Ge, Yuqiu, et al.
Publicado: (2020)

REST reduction is essential for hypoxia-induced neuroendocrine differentiation of prostate cancer cells by activating autophagy signaling
por: Lin, Tzu-Ping, et al.
Publicado: (2016)

Overexpressed ABCB1 Induces Olaparib-Taxane Cross-Resistance in Advanced Prostate Cancer()
por: Lombard, Alan P, et al.
Publicado: (2019)

MicroRNA let-7a: a novel therapeutic candidate in prostate cancer
por: Wu, Xiao-Qin, et al.
Publicado: (2014)

Exploring the Potential of MicroRNA Let-7c as a Therapeutic for Prostate Cancer
por: Mulholland, Eoghan J., et al.
Publicado: (2019)

Difference in Protein Expression Profile and Chemotherapy Drugs Response of Different Progression Stages of LNCaP Sublines and Other Human Prostate Cancer Cells
por: Lin, Hui-Ping, et al.
Publicado: (2013)

Epigenetic histone modification by butyrate downregulates KIT and attenuates mast cell function
por: Gudneppanavar, Ravindra, et al.
Publicado: (2023)

Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer
por: Wu, Meng-Jen, et al.
Publicado: (2021)

The phosphotyrosine-independent interaction of DLC-1 and the SH2 domain of cten regulates focal adhesion localization and growth suppression activity of DLC-1
por: Liao, Yi-Chun, et al.
Publicado: (2007)

Downregulation of IQGAP2 Correlates with Prostate Cancer Recurrence and Metastasis()
por: Xie, Yanyun, et al.
Publicado: (2018)

Histone Demethylase KDM4C Stimulates the Proliferation of Prostate Cancer Cells via Activation of AKT and c-Myc
por: Lin, Ching-Yu, et al.
Publicado: (2019)

Autophagy Pathway Is Required for IL-6 Induced Neuroendocrine Differentiation and Chemoresistance of Prostate Cancer LNCaP Cells
por: Chang, Pei-Ching, et al.
Publicado: (2014)

Arginine Signaling and Cancer Metabolism
por: Chen, Chia-Lin, et al.
Publicado: (2021)

Distinct microRNA Expression Profile in Prostate Cancer Patients with Early Clinical Failure and the Impact of let-7 as Prognostic Marker in High-Risk Prostate Cancer
por: Schubert, Maria, et al.
Publicado: (2013)

Targeting androgen receptor and the variants by an orally bioavailable Proteolysis Targeting Chimeras compound in castration resistant prostate cancer
por: Hung, Chiu-Lien, et al.
Publicado: (2023)

Quercetin reverses the doxorubicin resistance of prostate cancer cells by downregulating the expression of c-met
por: Shu, Yan, et al.
Publicado: (2018)

Downregulation of LOX promotes castration-resistant prostate cancer progression via IGFBP3
por: Chen, Xuanrong, et al.
Publicado: (2021)

Cystatin C Is Downregulated in Prostate Cancer and Modulates Invasion of Prostate Cancer Cells via MAPK/Erk and Androgen Receptor Pathways
por: Wegiel, Barbara, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_07hrmigcoqeqd41a6c89c4kv7t